PI3K pan-inhibition impairs more efficiently proliferation and survival of T-cell acute lymphoblastic leukemia cell lines when compared to isoform-selective PI3K inhibitors

JOURNAL ARTICLE published 30 April 2015 in Oncotarget

Authors: Annalisa Lonetti | Alessandra Cappellini | Antonino Maria Spartà | Francesca Chiarini | Francesca Buontempo | Camilla Evangelisti | Cecilia Evangelisti | Ester Orsini | James A. McCubrey | Alberto Maria Martelli